FAI Advisors, Inc.’s ImmuCell ICCC Stock Holding History

FAI Advisors, Inc.’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$263K	Buy	26,868 +59	+0.2%	+$615	0.1%	144
2026 Q2	$269K	Buy	26,809 +11	+0%	+$97	0.11%	142
2026 Q1	$170K	Hold	26,798	–	–	0.08%	163
2025 Q4	$165K	Hold	26,798	–	–	0.07%	163
2025 Q3	$167K	Hold	26,798	–	–	0.08%	167
2025 Q2	$187K	Hold	26,798	–	–	0.09%	158
2025 Q1	$128K	Hold	26,798	–	–	0.07%	157
2024 Q4	$138K	Buy	+26,798	New	+$107K	0.06%	170

Other funds holding ICCC

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Capital Advisors Ltd Shaker Heights, Ohio $987M AUM 13.52% 1-Year Est. Return

FAI Advisors, Inc.'s ICCC Position: Q3 2026 in Review

FAI Advisors, Inc. increased its ImmuCell (ICCC) stake by 0.22% in Q3 2026, buying an estimated $615 and bringing the position to 26,868 shares worth $263K. The position accounts for 0.1% of the portfolio, ranked #144.

FAI Advisors, Inc. first reported a position in ICCC in Q4 2024 and has held it in 8 quarters since. The position peaked at $269K in Q2 2026. 3 funds tracked by Wall St. Rank hold ICCC as of Q3 2026.

FAI Advisors, Inc. held 26,868 shares of ImmuCell worth $263K as of Q3 2026.
FAI Advisors, Inc. bought 59 ImmuCell shares in Q3 2026, an estimated $615.
ImmuCell made up 0.1% of FAI Advisors, Inc.'s portfolio in Q3 2026, its #144 holding.
FAI Advisors, Inc. first reported a position in ImmuCell in Q4 2024 and has held it in 8 quarters since.
FAI Advisors, Inc.'s ImmuCell position peaked at $269K in Q2 2026.
3 funds tracked by Wall St. Rank held ImmuCell as of Q3 2026.

Based on FAI Advisors, Inc.'s 13F filing for Q3 2026, filed 27 Oct 2026.